We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Travel and clinical advice on yellow fever including symptoms, diagnosis and epidemiology.
Information and guidance on a range of medical devices for users and patients.
Details of the Yellow Card scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
There have been very rare reports of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with pseudoephedrine.
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
Report a problem ('adverse incident') with a medical device or medicine to MHRA using the Yellow Card Scheme
The eighth annual #MedSafetyWeek social media campaign will take place from 6 to 12 November 2023. It will focus on the importance of reporting suspected adverse reactions to medicines and suspected problems with medical devices. We ask healthcare professionals to...
Guidance on listed diseases of fish and shellfish and their status in England and Wales, including what happens if a disease is suspected or confirmed.
Using an ecological momentary assessment to evaluate your digital health product.
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
This guide provides information about being arrested in Turkey and what conditions are like in prison there.
What to do if you have an electronic tag (including curfew tags, location tags and alcohol tags) and how to contact the Electronic Monitoring Service (EMS).
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Healthcare professionals should be vigilant for suspected adverse reactions and safety concerns associated with e-cigarettes and e-liquids, commonly known as vapes. Please report adverse reactions to the Yellow Card scheme and promote vigilance among patients.
You must declare if a public service vehicle (PSV) is exempt from needing a tachograph when you take it for its annual test (MOT).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.